Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wedbush Analyst Reiterates Outperform Rating for Rithm Capital with 13 Price Target

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Global supply chain
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Wedbush analyst Jay McCanless has once again expressed confidence in Rithm Capital (NYSE:RITM), reiterating an Outperform rating and a $13 price target. This reaffirmation underscores McCanless’s optimistic view of the company’s future prospects. According to TipRanks, a consensus of four analysts predicts an average 12-month price target of $11.75 for Rithm Capital, indicating a potential upside of 11.27% as of February 26, 2024.

RITM Stock Demonstrates Strong Performance: Trading Near 52-Week Highs and Above Moving Average

On February 26, 2024, RITM stock demonstrated strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend over a longer period of time.

The price of RITM shares increased by $0.01 since the market last closed, representing a 0.09% rise. The stock closed at $10.71, showing a slight increase during regular trading hours. Furthermore, RITM continued to show positive momentum as it rose by an additional $0.08 in after-hours trading.

Investors may view this positive price momentum as a bullish signal for RITM stock. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its past performance. Additionally, trading above its 200-day simple moving average indicates that the stock has been consistently trending upwards over a longer period of time.

It is important for investors to conduct thorough research and analysis before making any investment decisions. While past performance can provide some insights into the future potential of a stock, it is essential to consider other factors such as market conditions, company fundamentals, and industry trends.

RITM Stock Performance Analysis: Mixed Results for February 26, 2024

On February 26, 2024, RITM stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $3.79 billion, showing a significant increase of 86.85% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $1.42 billion.

In terms of net income, RITM reported a net income of $622.26 million for the past year, indicating a decrease of 34.81% compared to the previous year. In the last quarter, the company reported a net loss of $65.13 million, marking a substantial decrease of 130.11% since the previous quarter.

Earnings per share (EPS) for RITM were reported at $1.10 for the past year, showing a decrease of 38.67% compared to the previous year. In the last quarter, the company reported a negative EPS of -$0.18, which remained unchanged since the previous quarter.

Overall, RITM stock performances on February 26, 2024, reflected a mixed trend with significant increases in total revenue compared to the previous year, but decreases in net income and earnings per share. Investors may need to closely monitor the company’s financial performance and market conditions to make informed decisions about their investments in RITM stock.

Tags: RITM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mentorship

ZyVersa Therapeutics Makes Stunning Comeback After Trading Halt

Beverages Industry Markets and money (1)

Maintaining Positive Outlook on Keurig Dr Pepper Despite Recent Changes

Sleep

Deadline for LCNB Dividend Qualification Approaching

Recommended

Marvell Technology Stock

Trust Recognition Fuels Marvell Technology’s Market Momentum

3 months ago
Oxford Square Capital Stock

High-Yield Peril: Oxford Square Capital’s 25% Dividend Comes at a Steep Price

2 months ago
SCHW stock news

The Enigmatic Puzzle: Yousif Capital Management’s Intriguing Move on United States Steel Co.

2 years ago
Strategy Stock

Strategy Inc’s Pivot: A Sobering Reality Check for Investors

1 day ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

CureVac’s Final Chapter: Shareholders Seal Merger Fate

A Rally on Shaky Ground: The Dow’s Thin Tuesday Gains

Barrick Gold Unveils Radical Restructuring, Shares Hit Decade High

ASML Shares Surge Toward Unprecedented Highs

A Major European Contract Fuels Optimism for BWX Technologies

Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures

Trending

Cogent Biosciences Stock
Analysis

Cogent Biosciences Shares Face Pullback Following Stellar Rally

by Dieter Jaworski
December 3, 2025
0

After an extraordinary surge that saw its value multiply more than fourfold this year, Cogent Biosciences is...

Boeing Stock

Boeing Shares Surge on Renewed Financial Confidence

December 3, 2025
Kraft Heinz Stock

A Legal Avalanche Looms: Kraft Heinz Faces Landmark “Junk Food” Lawsuit

December 3, 2025
CureVac Stock

CureVac’s Final Chapter: Shareholders Seal Merger Fate

December 3, 2025
Dow Jones Stock

A Rally on Shaky Ground: The Dow’s Thin Tuesday Gains

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cogent Biosciences Shares Face Pullback Following Stellar Rally
  • Boeing Shares Surge on Renewed Financial Confidence
  • A Legal Avalanche Looms: Kraft Heinz Faces Landmark “Junk Food” Lawsuit

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com